2010 Epilepsy Pharmaceutical Treatment 
Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
Alchimia
JUNE 20, 2016
The exact CBD dosage still remains undefined by the science and greatly varies depending on the disease to treat; most treatments start with a dose of 1mg CBD per Kg of bodyweight, which is gradually increased if necessary. That could explain why kids using CBD to treat epilepsy may experience some of the side effects of THC, like sleepiness.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
AUGUST 8, 2020
The one exception is pharmaceutical-grade CBD products that have been approved by the FDA, which currently only includes one medication: Epidiolex. As discussed with Epidiolex, CBD is also effective at treating epilepsy and seizures. CBD Scheduling Rule Change. CBD & Epidiolex. So what exactly is Epidiolex ? Glad you asked!
Cannabis Law Report
OCTOBER 20, 2019
She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. They include, but are not limited to, the synthetic marijuana pharmaceutical companies; the Canadian marijuana industry; the alcohol industry; the pharmaceutical industry in general; the drug testing industry, and, the government.
Cannabis Law Report
JUNE 26, 2019
I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years.
Cannabis Law Report
JANUARY 3, 2022
TASE: PNAX), a global pharma company that develops, manufactures and markets progressive cannabis-based products in pharmaceutical quality, announced today that it has received official approval for the EU-GMP standard for its production facility in Malta from EU Health Authority. SOURCE Panaxia Pharmaceutical Industries.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.
Expert insights. Personalized for you.
71 
Let's personalize your content